Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Short-term Investments (2017 - 2022)

Medicure has reported Short-term Investments over the past 6 years, most recently at $2300.2 for Q3 2022.

  • For Q3 2022, Short-term Investments fell 99.72% year-over-year to $2300.2; the TTM value through Sep 2022 reached $2300.2, down 99.72%, while the annual FY2021 figure was $2380.0, 99.78% down from the prior year.
  • Short-term Investments for Q3 2022 was $2300.2 at Medicure, down from $2353.0 in the prior quarter.
  • Over five years, Short-term Investments peaked at $45.9 million in Q1 2018 and troughed at $2300.2 in Q3 2022.
  • A 5-year average of $15.4 million and a median of $818241.6 in 2021 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: dropped 25.58% in 2019 and later crashed 99.78% in 2021.
  • Year by year, Short-term Investments stood at $36.2 million in 2018, then dropped by 5.56% to $34.2 million in 2019, then crashed by 96.87% to $1.1 million in 2020, then crashed by 99.78% to $2380.0 in 2021, then decreased by 3.35% to $2300.2 in 2022.
  • Business Quant data shows Short-term Investments for MCUJF at $2300.2 in Q3 2022, $2353.0 in Q2 2022, and $2368.4 in Q1 2022.